Jun 2026 (Q3 FY26) — Aug 12, 2026
NANO Nuclear Energy Q3 FY26 — Kronos MMR Advances, Strategic Acquisitions & Multi-Gigawatt Pipeline
Read the full callNANO Nuclear Energy (NNE) earnings
- Jun 2026
- Jun 2026 (Q3 FY26)
- Sep 2025
NANO Nuclear Energy earnings: last reported Wed, 12 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 0.21 | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. | |
| Operating margin | -7393.7 | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. | |
| Net profit | -10.1 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$13.01 +1.01% · +$0.13
Performance −72.8% 1Y
1Y: $47.84 on 17 Oct 2025 → $13.01. High $47.84 (17 Oct 2025), low $12.88 (16 Oct 2026).
- Previous close
- $12.88
- 52-week range
- $12.88 – $47.83
- One year
- −71.76%
Overview
- Symbol
- NNE
- Sector
- Industrials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
NANO Nuclear Energy earnings calls (NNE)
Financials
What the filings say
Net profit, year on year: −33% (quarter to jun 2026 against jun 2025).
| Line item | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | — | — | — | — | — | — | — | 0 |
| Operating profit | — | — | — | — | -9 | — | — | -16 |
| Operating margin | — | — | — | — | — | — | — | −7393.7% |
| Net profit | -5 | -2 | -3 | -21 | -8 | -7 | -9 | -10 |
| EPS ($ per share) | -0.17 | — | -0.09 | -0.57 | -0.19 | -0.13 | -0.18 | -0.19 |
| Line item | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|
| Equity capital | 0 | 0 | 0 |
| Reserves | -7 | -17 | -58 |
| Total liabilities | 0 | 3 | 6 |
| Fixed assets | — | 2 | 10 |
| Total assets | 7 | 35 | 229 |
| Line item | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|
| Cash from operations | -4 | -8 | -20 |
| Cash from investing | — | -4 | -18 |
| Cash from financing | 9 | 34 | 212 |
| Net cash flow | 5 | 22 | 175 |
| Capital expenditure | — | -2 | -8 |
| Free cash flow | — | -10 | -28 |
Insider filings
132 filings between Dec 23, 2025 and Sep 3, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$174.72M
94 sales by 9 insiders
97% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 38
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Yu Jiang | — | $83.87M | Sep 2, 2026 |
| I Financial Ventures Group LLC | — | $74.37M | Jun 3, 2026 |
| Walker James John | — | $8.27M | Sep 3, 2026 |
| Garcha Jaisun | — | $3.54M | Jun 3, 2026 |
| Law Tsun Yee | — | $1.78M | Dec 23, 2025 |
| Hare Diane Elizabeth | — | $1.31M | Jun 3, 2026 |
| Yu Kenny Joe Yung | — | $1.30M | Dec 23, 2025 |
| Berl Seth Jason | — | $194.9K | Jun 5, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Walker James John Chief Executive Officer | Sale 10b5-1 plan | 25,000 | $444.2K |
| Sep 2, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 141,931 | $2.48M |
| Sep 1, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 332,569 | $5.80M |
| Sep 1, 2026 | Walker James John Chief Executive Officer | Sale 10b5-1 plan | 25,000 | $436.1K |
| Jun 5, 2026 | Heidet Florent Chief Technology Officer | Sale | 3,000 | $74.9K |
| Jun 5, 2026 | Berl Seth Jason Director | Sale | 3,750 | $93.5K |
| Jun 3, 2026 | Walker James John Chief Executive Officer | Option exercise | 200,000 | $600.0K |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Sale 10b5-1 plan | 312,553 | $8.22M |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 700 | $20.9K |
| Jun 3, 2026 | Garcha Jaisun Chief Financial Officer | Option exercise 10b5-1 plan | 20,000 | $60.0K |
| Jun 3, 2026 | Heidet Florent Chief Technology Officer | Option exercise | 9,185 | $0 |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Sale 10b5-1 plan | 125,021 | $3.29M |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Sale 10b5-1 plan | 67,451 | $1.83M |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Sale 10b5-1 plan | 4,014 | $111.7K |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Sale 10b5-1 plan | 5,215 | $156.0K |
| Jun 3, 2026 | Garcha Jaisun Chief Financial Officer | Sale 10b5-1 plan | 15,223 | $408.6K |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Sale 10b5-1 plan | 3,571 | $103.5K |
| Jun 3, 2026 | Garcha Jaisun Chief Financial Officer | Option exercise 10b5-1 plan | 17,215 | $0 |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 1,400 | $39.0K |
| Jun 3, 2026 | Garcha Jaisun Chief Financial Officer | Sale 10b5-1 plan | 1,761 | $48.6K |
| Jun 3, 2026 | Garcha Jaisun Chief Financial Officer | Sale 10b5-1 plan | 174 | $5.0K |
| Jun 3, 2026 | Garcha Jaisun Chief Financial Officer | Sale 10b5-1 plan | 57 | $1.7K |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Option exercise 10b5-1 plan | 200,000 | $600.0K |
| Jun 3, 2026 | Berl Seth Jason Director | Option exercise | 7,500 | $0 |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 312,553 | $8.22M |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 168,626 | $4.58M |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 10,035 | $279.3K |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 3,571 | $103.5K |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 5,215 | $156.0K |
| Jun 3, 2026 | Yu Jiang President and Chairman | Option exercise 10b5-1 plan | 200,000 | $600.0K |
| Jun 3, 2026 | Garcha Jaisun Chief Financial Officer | Sale 10b5-1 plan | 20,000 | $521.7K |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Sale 10b5-1 plan | 10,035 | $279.3K |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 1,429 | $41.4K |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 4,014 | $111.7K |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 2,085 | $62.4K |
| Jun 3, 2026 | Yu Jiang President and Chairman | Option exercise 10b5-1 plan | 45,900 | $0 |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 30,250 | $795.3K |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 13,050 | $353.2K |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Sale 10b5-1 plan | 2,085 | $62.4K |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 500 | $14.4K |
| Jun 3, 2026 | Hare Diane Elizabeth Director | Option exercise 10b5-1 plan | 3,428 | $0 |
| Jun 3, 2026 | Hare Diane Elizabeth Director | Sale 10b5-1 plan | 2,228 | $58.6K |
| Jun 3, 2026 | Hare Diane Elizabeth Director | Sale 10b5-1 plan | 1,000 | $27.0K |
| Jun 3, 2026 | Hare Diane Elizabeth Director | Sale 10b5-1 plan | 100 | $2.8K |
| Jun 3, 2026 | Hare Diane Elizabeth Director | Sale 10b5-1 plan | 100 | $2.9K |
| Jun 3, 2026 | Law Tsun Yee Director | Option exercise | 3,428 | $0 |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 67,451 | $1.83M |
| Jun 3, 2026 | Yu Jiang President and Chairman | Sale 10b5-1 plan | 125,021 | $3.29M |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Sale 10b5-1 plan | 1,429 | $41.4K |
| Jun 3, 2026 | I Financial Ventures Group LLC 10% owner | Sale 10b5-1 plan | 168,626 | $4.58M |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Nano Nuclear Energy Inc.
Free account. Everything above stays public.
Write why you follow Nano Nuclear Energy Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading